Open Access Open Access  Restricted Access Subscription or Fee Access

Ventilator Associated Pneumonia: Prevalence of Bacteria and their Antibiogram in Tertiary Care Centre, Kota, Rajasthan, India

Nikhil Mathur, Deepmala Nahar, Ghanshyam Soni, Charu Sharma, Gopal Lal Meena


Background: Mechanical ventilation is a life-saving procedure, but it is associated with a high risk of acquiring respiratory infections. Hence to prevent it and initiate empirical antimicrobial therapy, knowledge of microbial profile and their local antimicrobial sensitivity pattern are essential. The study aimed to investigate the role of endotracheal aspirate (ETA) surveillance cultures in identifying the aetiology of VAP earlier. Methods: A prospective study was carried out over a period of 1 year in the ICU of a tertiary care hospital. All patients on mechanical ventilation for more than 48 h were included in the study. Results: Endo-tracheal aspirates were taken from 100 patients who were mechanically ventilated for more than 48 h and were subjected to culture and antibiotic susceptibility. 27 patients were culture positive (30 isolates) and diagnosed as VAP. Gram negative bacteria were isolated from most of the patients, most common being Klebsiella species, followed by Pseudomonas and Acinetobacter. Among gram positive Staphylococcus aureus was isolated. Conclusion: Gram negative bacteria were the major pathogenic organisms of VAP in our ICU. Culture of endotracheal aspirates for early diagnosis and its antibiogram will guide for an approach to targeted treatment.


Intensive care unit (ICU), Ventilator associated pneumonia (VAP), Mechanical ventilator (MV), aetiology, endotracheal aspirate (ETA)

Full Text:



Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and Economic Consequences of Ventilator-Associated Pneumonia: A Systematic Review. Crit Care Med. 2005; 33(10): 2184–93p.

Pingleton S, Hinthorn D, Liu C. Enteral Nutrition in Patients Receiving Mechanical Ventilation: Multiple Sources of Tracheal Colonization Include the Stomach. Am J Med. 1986; 80(5): 827–832p.

Apostolopoulou E, Bakakos P, Katostaras T, Gregorakos L. Incidence and Risk Factors for Ventilator-Associated Pneumonia in 4 Multidisciplinary Intensive Care Units in Athens, Greece. Respir Care. 2003; 48(7): 681–688p.

Koenig S, Truwit JD. Ventilator‐Associated Pneumonia: Diagnosis, Treatment, and Prevention. Clin Micr Reviews. 2006; 19(4): 637–657p.

Fagon J, Chastre J, Hance A, Montravers P, Novara A, Gibert C. Nosocomial Pneumonia in Ventilated Patients: A Cohort Study Evaluating Attributable Mortality and Hospital Stay. Am J Med. 1993; 94(3): 281–288p.

Rello J, Ollendorf D, Oster G, Vera‐Llonch M, Bellm L, Redman R, Kollef M. Epidemiology and Outcomes of Ventilator‐Associated Pneumonia in a Large US Database. Chest. 2002; 122(6): 2115–2121p.

Kollef M, Silver P, Murphy D, Trovillion E. The Effect of Late (Onset Ventilator) Associated Pneumonia in Determining Patient Mortality. Chest. 1995; 108(6): 1665–1662l.

Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of Adults with Hospital-Acquired and Ventilator-Associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016; 63(5): e61–e111p.

Reena, et al. Bacteriological Profile among Patients with Ventilator-Associated Pneumonia from a Medical Intensive Care Unit at Tertiary Care Center in Mumbai. Indian J Pathol Microbiol. 2011; 54(2): 432–433p.

Joseph NM, Sisttla S, Dutta TK, et al. Ventilator Associated Pneumonia in a Tertiary Care Hospital in India- Role of Multidrug Resistant Pathogens. J Infect Dev Ctries. 2010; 4(4):



  • There are currently no refbacks.